FDA Drug Recalls

Recalls / Class II

Class IID-0939-2018

Product

NORepiNEPHrine 8 mg (norepinephrine Bitartrate (USP) 8 mg added to 5% Dextrose Inj. (USP) 250 mL. (Concentration 32 mcg/mL) Volume: 258 mL. Single dose bag. Avella of Houston, 9265 Kirby Dr. Houston, TX 77054. NDC 42852-815-25

Affected lot / code info
Lot #4/23/18 0101 81525P, 4/23/18 1020 81525P, BUD 6/22/2018;4/30/18 1123 81525P, 4/30/18 1311 81525P, BUD 6/29/2018; 5/1/18 3456 81525P, BUD 6/30/2018; 5/8/18 3213 81525P, BUD 7/7/2018.

Why it was recalled

Lack of Assurance of Sterility: Potential leakage of bags.

Recalling firm

Firm
Avella of Deer Valley, Inc. Store 38
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
24416 N 19th Ave, Phoenix, Arizona 85085-1887

Distribution

Quantity
4,280 bags
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2018-06-12
FDA classified
2018-07-19
Posted by FDA
2018-07-25
Terminated
2020-01-24
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0939-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls